November 29, 2016 / 10:32 PM / 10 months ago

BRIEF-Quest Pharmatech says positive interim results from mid-stage clinical study of Oregovomab

Nov 29 (Reuters) - Quest Pharmatech Inc

* Quest Pharmatech says positive interim results from phase 2b clinical study of Oregovomab

* Quest Pharmatech Inc- Oregovomab in combination with chemotherapy improves clinical outcome in ovarian cancer patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below